92584-63-9

Basic information

• Product Name: 1-Propanol, 3-(3-bromophenoxy)-
• CAS NO: 92584-63-9
• Molecular Formula: C9H11BrO2
• Molecular Weight: 231.089
• Mol File: 92584-63-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-Propanol, 3-(3-bromophenoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Propanol, 3-(3-bromophenoxy)-(92584-63-9)
• EPA Substance Registry System: 1-Propanol, 3-(3-bromophenoxy)-(92584-63-9)

Safety Data

• Hazardous Substances Data: 92584-63-9(Hazardous Substances Data)

Usage

General Description

1-Propanol, 3-(3-bromophenoxy)- is a chemical compound with the formula C9H11BrO2. It is a derivative of 1-propanol, with a 3-(3-bromophenoxy) group attached to the third carbon atom. 1-Propanol, 3-(3-bromophenoxy)- is used in organic synthesis as a starting material for the production of other chemicals. It may also have applications in pharmaceuticals or as a chemical intermediate for the production of other compounds. The presence of the bromophenoxy group makes this compound potentially useful in the development of biologically active molecules, and further research may uncover more potential uses for this chemical.

Upstream product

• 591-20-8 3-Bromophenol 
• 627-18-9 1-bromo-3-propanol 

Downstream Products

• 127973-09-5 3-(3-bromophenoxy)propanal 
• 1429323-82-9 C₁₇H₁₉N₅O₃ 
• 1429323-81-8 C₃₄H₄₇N₅O₉ 
• 1429323-80-7 C₁₇H₂₅BO₅ 
• 129789-91-9 3-(3-bromo-phenoxy)-propionic acid ethyl ester 
• 18386-03-3 3-(3-bromophenoxy)propionic acid 
• 156450-01-0 1-bromo-3-(3-bromopropoxy)benzene 

Relevant articles and documents

Structure-activity relationship of biaryl acylsulfonamide analogues on the human EP3 prostanoid receptor

Potent and selective ligands for the human EP3 prostanoid receptor are described. Biaryl compounds bearing a tethered ortho substituted acidic moiety were identified as potent EP3 antagonists based on the SAR described herein. The binding affinity of key compounds on all eight human prostanoid receptors is reported.

MACROCYCLIC LRRK2 KINASE INHIBITORS

The present invention relates to novel macrocylic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of LRRK2 (Leucine-Rich Repeat Kinase 2). Moreover, the present invention provides processes for the preparation of the disclosed compounds, as well as methods of using them, for instance as a medicine or diagnostic agent, in particular for the treatment and/or diagnosis of diseases characterized by LRRK2 kinase activity such as neurological disorders including Parkinson's disease and Alzheimer's disease